Evotec (EVO) announced the appointment of Ingrid Muller as COO. Muller will be joining Evotec’s management board, effective May 1. In her role as COO, Muller will oversee Evotec’s global operations and implementation of the Horizon initiative. Most recently, Muller served as VP portfolio strategy and execution at CureVac (CVAC).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Limited Near-Term Visibility and Execution Risk Drive Sell Rating on Evotec Despite In-Line Results
- Evotec Earnings Call: Biologics Surge Amid Tough Reset
- Evotec Posts Strong 2025 Results and Accelerates Horizon Transformation With Major Biologics Deals
- Evotec Names New Supervisory Board Chair and Expects $100 Million Windfall From Tubulis Deal
- EVO Upcoming Earnings Report: What to Expect?